DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Entry inhibitor
Entry inhibitor
Design and Evaluation of 5•²-O-Dicarboxylic And
Biochemical Engineering: Ta Da! a Way to Add Fluorine to Natural Products
14-258 Phrma HIV/AIDS2014 0819.Indd
Management of Hiv Infection
The Entry of Entry Inhibitors: a Fusion of Science and Medicine
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-Oncology Xuanmao Jiao1, Omar Nawab1,2,Tejal Patel2, Andrew V
Targeting Cell Entry of Enveloped Viruses As an Antiviral Strategy
Antiretroviral Drugs Impact Autophagy with Toxic Outcomes
SARS-Cov-2: an Update on Potential Antivirals in Light of SARS-Cov Antiviral Drug Discoveries
Antiviral Research and Development Against Dengue Virus
How Entry Inhibitors Work
Full PDF of 2003 Pipeline Report
Adverse Effects of Antiretroviral Medications
Antiviral Drugs in the Treatment of Aids: What Is in the Pipeline ?
UNIVERSITY of CALIFORNIA, MERCED Purification and Study Of
Tenofovir Disoproxil Fumarate Fixed-Dose Combination
Protease Inhibitors (Ritonavir and ASC09) in Clinical Trials to Treat COVID-19, the Illness Caused by the New Coronavirus (Table 1)
Maraviroc (Celsentri)
Top View
CCR5 Inhibitors and HIV-1 Infection
Cytodyn Announces Preliminary Results from 30 Mtnbc Patients Treated with Leronlimab
Entry Inhibitors
Field-Based Affinity Optimization of a Novel Azabicyclohexane Scaffold
Epigallocatechin Gallate, the Main Polyphenol in Green Tea, Binds to the T-Cell Receptor, CD4: Potential for HIV-1 Therapy
Non-Nucleoside Reverse Transcriptase
Enfuvirtide: the First Therapy to Inhibit the Entry of Hiv-1 Into Host Cd4 Lymphocytes
Metabolic and Body Composition Effects of Newer Antiretrovirals in HIV-Infected Patients
Cytodyn Inc. (Exact Name of Registrant As Specified in Its Charter)
HIV-1 Entry and Membrane Fusion Inhibitors
Natural Barrier to HIV-1 Entry
Parenteral Inhibitors of HIV Entry in Current Development The
Compound Name References: Xxx,Xxx Proprietary Name Systematic/Other Names Notes
Selected Properties of Vicriviroc **In October 2005, Schering Plough
HIV-1 Entry, Inhibitors, and Resistance
Chlorogenic Compounds from Coffee Beans Exert Activity Against Respiratory Viruses
Page: Treatment-Drugs
Epigallocatechin Gallate from Green Tea Effectively Blocks Infection of SARS-Cov-2 And